ADDvise Group (ADDV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Net revenue declined 6.1% year-over-year in Q2 2026, with organic revenue down 5.0% due to cautious capital equipment investments and geopolitical disruptions, especially in the Middle East.
Order intake increased 0.6% in Q2 and 1.6% for H1 2026, with organic order growth of 7.4% year-to-date, supporting a positive outlook.
Cash flow from operating activities improved significantly, up 158.5% in Q2 and 58.7% for H1 2026, driven by lower financing costs and better working capital.
The group became a subsidiary of Amplex AB, resulting in delisting from Nasdaq and a change to a non-calendar financial year.
Financial highlights
Q2 2026 net revenue: SEK 372.0 million (down 6.1% year-over-year); H1 2026: SEK 729.4 million (down 11.1%).
Q2 EBITA: SEK 41.8 million (down 31.9%); EBITA margin 11.2% (down from 15.5%).
Q2 operating profit (EBIT): SEK 9.1 million (down from SEK 50.2 million); H1 EBIT: SEK 48.1 million (down from SEK 119.5 million).
Loss for Q2: SEK -14.0 million (improved from SEK -82.8 million); adjusted profit for Q2: SEK 8.8 million.
Basic EPS for Q2: SEK -0.02; H1: SEK -0.01.
Operating cash flow Q2: SEK 43.5 million (up from SEK 16.8 million); H1: SEK 84.7 million (up from SEK 53.4 million).
Outlook and guidance
Stable order intake and strong organic order growth provide confidence for future periods.
Management remains focused on profitability, cash flow improvement, and reducing indebtedness, with continued selective acquisitions.
Financial position is stable, with all covenant requirements fulfilled.
Latest events from ADDvise Group
- Revenue and profit fell sharply, but order intake and cash flow showed resilience.ADDV
Q1 2026 - Q4 saw higher EBITA margin, improved cash flow, and delisting after Amplex's takeover.ADDV
Q4 2025 - Profitability and cash flow rose on higher margins and lower financing costs, despite sales declines.ADDV
Q3 2025 - Margins and cash flow improved as new financing reduced debt and supported growth.ADDV
Q2 2025 - Sales and order intake up 26% and 17%, but margins fell and net debt rose amid tough comparables.ADDV
Q3 2024 - Sales up 20% with record orders, but organic growth and margins under pressure; liquidity remains strong.ADDV
Q2 2024 - Sales up 2.6–3%, EBITA margin 17.8–18%, and SEK 457m rights issue cut leverage.ADDV
Q1 2025 - Q4 2024 saw 11% sales growth and a SEK 457m rights issue to reduce debt and support growth.ADDV
Q4 2024